Cardiac amyloidosis

Cardiac amyloidosis happens when an abnormal protein called amyloid builds up in the heart muscle and forms deposits. The deposits can leave the heart stiff and unable to work the way it should, and people may have an abnormal heartbeat or an enlarged heart. It is one cause of cardiomyopathy. Amyloid can build up in other organs too, such as the kidney. In the United States the label of the medicine tafamidis gives cardiomyopathy caused by one type of amyloid in adults as its indication.

  • Condition
  • In this atlas

Overview

Technical summary

MeSH has no descriptor for cardiac amyloidosis. The wider descriptor Amyloidosis (D000686) is recorded here as a broad match; its scope note describes diseases linked by abnormal protein folding and deposition of amyloid. The MedlinePlus Genetics page describes a cardiac form of transthyretin amyloidosis, and the US tafamidis label names the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM). Other types of amyloidosis can also involve the heart; this page does not separate the types.

Classification codes

  • MeSH MeSH linked-data concept M0001053 of descriptor D000686 (Amyloidosis) fetched on 2026-10-30; the descriptor is wider than this record D000686

Burden

No burden claims are published.

Claims and evidence

Context People with amyloidosis that affects the heart, as described in MeSH and MedlinePlus reference pages

Recipient
Recipient not specified
Population
People with amyloidosis, with emphasis on involvement of the heart. The pages are written for the public or as a vocabulary and give no study population, age range or risk group. The MedlinePlus Genetics page describes the transthyretin type.
Care setting
General health information for the public; no care setting is stated
Geography
United States (pages of US government agencies); the MeSH vocabulary is international
Life stage
Not stated in the pages for the heart form
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (descriptive statement)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
Included
None stated
Excluded
None stated
  • Description Evidence stage unknown Certainty not assessed

    The MeSH scope note for amyloidosis describes a group of diseases linked by abnormal protein folding and deposition of amyloid, with the deposits displacing normal tissue and disrupting its function. MedlinePlus says abnormal proteins called amyloids build up and form deposits, that the deposits can collect in organs such as the kidney and heart, and that this can leave an organ stiff and unable to work as it should. MedlinePlus Genetics says the cardiac form of transthyretin amyloidosis affects the heart and that people with cardiac amyloidosis may have an abnormal heartbeat and an enlarged heart.

    Applies to Recipient not specified People with amyloidosis that affects the heart, as described in MeSH and MedlinePlus reference pages

    Certainty method
    Not assessed
    Limitations
    Vocabulary and patient-education pages from US government sources. MeSH has no descriptor for cardiac amyloidosis, so the scope note describes amyloidosis as a whole. The MedlinePlus Genetics page describes the transthyretin type only, and its list of cardiac findings is quoted only in part because the page's wording of the last finding looks like a source error. The pages give no study, no size of risk and no population beyond the general public.
    Last checked
    2026-10-30
    Next evidence check due
    Not scheduled
    Sources and citations (6)
    1. Supports MeSH scope note for descriptor D000686 (Amyloidosis)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0001053 of descriptor D000686, fetched 2026-10-30. The scope note is on this concept record, not on the descriptor record. · MeSH: M0001053

      Locator
      scopeNote.@value
      How it applies
      MeSH scope note of the descriptor Amyloidosis, which is wider than the heart form.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      54d0563e45b3bf8fa1c1bee0c833fb7035d74e96a0978f111ad84c17bac6d595
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    2. Supports Amyloidosis (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated July 5, 2026.

      Locator
      Summary, para 1, sentence 1
      How it applies
      What amyloidosis is.
      Retrieved
      Source effective date
      2026-07-05
      Source state
      Current
      Version fingerprint
      180c57d16d5511de7fadf3cc7fe19969b5d0139c61948bd94bd9bdbea5fd3604
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    3. Supports Amyloidosis (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated July 5, 2026.

      Locator
      Summary, para 1, sentence 2
      How it applies
      Organs where the deposits collect.
      Retrieved
      Source effective date
      2026-07-05
      Source state
      Current
      Version fingerprint
      180c57d16d5511de7fadf3cc7fe19969b5d0139c61948bd94bd9bdbea5fd3604
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    4. Supports Amyloidosis (MedlinePlus health topic)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated July 5, 2026.

      Locator
      Summary, para 1, sentence 3
      How it applies
      Effect on the organs.
      Retrieved
      Source effective date
      2026-07-05
      Source state
      Current
      Version fingerprint
      180c57d16d5511de7fadf3cc7fe19969b5d0139c61948bd94bd9bdbea5fd3604
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    5. Supports Transthyretin amyloidosis (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated November 8, 2023. Its paragraph on the cardiac form lists orthostatic hypertension, while its paragraph on the neuropathic form lists a sharp drop in blood pressure on standing (orthostatic hypotension), so the cardiac-form wording looks like a source error and is not used here.

      Locator
      Description, para 4, sentence 1
      How it applies
      The cardiac form of transthyretin amyloidosis.
      Retrieved
      Source effective date
      2023-11-08
      Source state
      Current
      Version fingerprint
      2defdb0688632ca71f852b099c8cf88007a300011d1f7ac09aee892ddf87379c
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    6. Supports Transthyretin amyloidosis (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated November 8, 2023. Its paragraph on the cardiac form lists orthostatic hypertension, while its paragraph on the neuropathic form lists a sharp drop in blood pressure on standing (orthostatic hypotension), so the cardiac-form wording looks like a source error and is not used here.

      Locator
      Description, para 4, sentence 2 (first part)
      How it applies
      First two findings of the list.
      Retrieved
      Source effective date
      2023-11-08
      Source state
      Current
      Version fingerprint
      2defdb0688632ca71f852b099c8cf88007a300011d1f7ac09aee892ddf87379c
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 19

Record details

Record id
cardio:cardiac-amyloidosis
Content hash
1ec06350245a489adcab76a2036284dfa48f8db9bf2086d8307278dc2906521f